Novel Surgical Technique For Female Distal Urethral Stricture Disease: An Evaluation Of Efficacy And Safety Compared With Urethral Dilatation

Ting-Ting Tao,Qing-Kang Xu,Qing Hu,Xiao-Jun Huang,Jun Chen,Wen-Zhi Wang,Bo-Dong Lv,Yue Duan
2018-01-01
Abstract:Objective: The aim of this study was to review the efficacy and safety of the use of a dorsal-onlay pedicled labium flap for urethroplasty and urethral dilatation in the treatment of female urethral strictures (FUS). Patients and methods: A retrospective review of 22 women with FUS was conducted. Ten of these patients received urethral dilatation while the other twelve patients were treated with dorsal-onlay pedicled labium flap urethroplasty. All patients underwent pre-treatment and post-treatment evaluation. Results: One patient receiving urethral dilatation was lost to follow up 7 months after treatment. Others were evaluated at 12th months. Range of the follow-up period was 7-12 months. Range of follow-ups in the surgical group was 6-15 months. According to statistical analysis, quality of life (QOL), American Urological Association (AUA) symptom scores, urination symptom scores, and post-void residual (PVR) and maximum flow rates (MFR) were all obviously improved in both two groups (P<0.05). Comparing the two forms of therapy, there were no significant changes in terms of AUA symptom scores, urination symptom scores, and PVR (P>0.05), although post-surgical median QOL and MFR were significantly better than urethral dilatation at the last follow-up (P<0.05). No complications were observed during or after urethroplasty and no recurrence or recurrent urinary tract infections were reported during follow-up. Conclusion: Urethral dilatation and dorsal-onlay pedicled labium flap urethroplasty can be used in the treatment of FUS. However, urethroplasty can resolve FUS in one application without complications, with greater advantages in terms of patient satisfaction and MFR.
What problem does this paper attempt to address?